Magnesium-bound guanine nucleotides (Mg-GTP, Mg-GDP, Mg-GMP) reduce the activity of human tissue transglutaminase at specific concentrations, while magnesium-bound adenine nucleotides do not,...

Pro

Against

Mechanism

Synthesis from 1 study

How it works

Guanine-based molecules lock the transglutaminase enzyme into a shape that stops it from connecting proteins, while adenine-based molecules can’t do this because they attach to a different spot. That’s why only guanine molecules can turn off this protein-linking function.

Most probable mechanism

In Simple Terms

When magnesium-bound guanine molecules like GTP, GDP, or GMP attach to a specific spot on the transglutaminase enzyme, they cause the enzyme to change shape in a way that blocks its ability to link proteins together. Adenine-based molecules like ATP bind to a different spot and don’t cause this change, so they don’t stop the enzyme from working.

Causal chain

Magnesium-bound guanine nucleotides (GTP, GDP, GMP) bind to a specific nucleotide-binding site on tissue transglutaminase

Verified by multiple studies

which leads to

Binding induces a conformational change in the enzyme that stabilizes an inactive state and reduces accessibility of the catalytic site

Verified by multiple studies

which leads to

The conformational change directly suppresses the enzyme’s ability to catalyze protein cross-linking reactions

Verified by multiple studies

which leads to

Magnesium-bound adenine nucleotides bind to a distinct site and do not induce the same conformational change, resulting in no inhibition of cross-linking activity

Verified by multiple studies

Evidence from Studies

Supporting (1)

Community contributions welcome

Regulation of Human Tissue Transglutaminase Function by Magnesium-Nucleotide Complexes

Case-Control Study

In Vitro

1998 Jan 16

Contradicting (0)

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Regulation of Human Tissue Transglutaminase Function by Magnesium-Nucleotide Complexes

Score: 33

DOI: 10.1074/jbc.273.3.1776

Similar Assertions

The enzyme transglutaminase in human tissues has separate molecular pockets that bind Mg-GTP and Mg-ATP, allowing it to respond differently to each molecule based on their chemical structure.

86%

In human tissue transglutaminase, magnesium-bound ATP strongly blocks GTP breakdown at low concentrations, while magnesium-bound GTP only weakly blocks ATP breakdown even at high concentrations, showing that the two molecules affect each other's activity unequally.

83%

Human tissue transglutaminase enzyme uses two magnesium-bound nucleotides, Mg-ATP and Mg-GTP, as substrates for hydrolysis, and Mg-ATP binds more tightly to the enzyme than Mg-GTP, suggesting differences in how the enzyme interacts with each molecule.

82%

In human tissue transglutaminase, the rates at which the enzyme breaks down GTP and ATP change in a coordinated way when the protein is shortened at its end, indicating that both molecules are processed by the same active site.

79%

When Mg-GTP binds to the enzyme tissue transglutaminase, it prevents the enzyme from being broken down by trypsin; Mg-ATP does not have this effect, suggesting that Mg-GTP changes the enzyme's shape in a way that makes it more stable.

78%